Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Proxy Solicitation & Information Statement 2025

Jul 17, 2025

6785_rns_2025-07-17_7c4d65bf-aa51-4ba6-b68f-297c70c3a437.htm

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 381
EVOGENE LTD
Corporation no: 512838723 14299
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 17/07/2025
www.isa.gov.il www.tase.co.il Reference: 2025-02-053352 Time of broadcast: 17:44 17:44

The corporation scheduled the publication of the report to 17/07/2025 23:00Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Supplemental Submission of Proxy Card for Annual General Meeting of Shareholders

6K_EVGN_proxy_card_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2025-02-043133
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 06/08/2024
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1